154 related articles for article (PubMed ID: 37532578)
1. Toxicological applications of human induced pluripotent stem cell-derived hepatocyte-like cells: an updated review.
Gao X; Yourick JJ; Sprando RL
J Toxicol Sci; 2023; 48(8):441-456. PubMed ID: 37532578
[TBL] [Abstract][Full Text] [Related]
2. A transcriptomic study suggesting human iPSC-derived hepatocytes potentially offer a better in vitro model of hepatotoxicity than most hepatoma cell lines.
Gao X; Liu Y
Cell Biol Toxicol; 2017 Aug; 33(4):407-421. PubMed ID: 28144825
[TBL] [Abstract][Full Text] [Related]
3. Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening.
Gómez-Lechón MJ; Tolosa L
Arch Toxicol; 2016 Sep; 90(9):2049-2061. PubMed ID: 27325232
[TBL] [Abstract][Full Text] [Related]
4. Donor-Dependent and Other Nondefined Factors Have Greater Influence on the Hepatic Phenotype Than the Starting Cell Type in Induced Pluripotent Stem Cell Derived Hepatocyte-Like Cells.
Heslop JA; Kia R; Pridgeon CS; Sison-Young RL; Liloglou T; Elmasry M; Fenwick SW; Mills JS; Kitteringham NR; Goldring CE; Park BK
Stem Cells Transl Med; 2017 May; 6(5):1321-1331. PubMed ID: 28456008
[TBL] [Abstract][Full Text] [Related]
5. Advances in Human Induced Pluripotent Stem Cell-Derived Hepatocytes for Use in Toxicity Testing.
Wills LR; Rajagopalan P
Ann Biomed Eng; 2020 Mar; 48(3):1045-1057. PubMed ID: 31372857
[TBL] [Abstract][Full Text] [Related]
6. Analysis of differentially expressed genes among human hair follicle-derived iPSCs, induced hepatocyte-like cells, and primary hepatocytes.
Xu Z; He X; Shi X; Xia Y; Liu X; Wu H; Li P; Zhang H; Yin W; Du X; Li L; Li Y
Stem Cell Res Ther; 2018 Aug; 9(1):211. PubMed ID: 30092828
[TBL] [Abstract][Full Text] [Related]
7. hiPSC-derived hepatocytes closely mimic the lipid profile of primary hepatocytes: A future personalised cell model for studying the lipid metabolism of the liver.
Kiamehr M; Alexanova A; Viiri LE; Heiskanen L; Vihervaara T; Kauhanen D; Ekroos K; Laaksonen R; Käkelä R; Aalto-Setälä K
J Cell Physiol; 2019 Apr; 234(4):3744-3761. PubMed ID: 30146765
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte-like cells derived from human induced pluripotent stem cells using small molecules: implications of a transcriptomic study.
Gao X; Li R; Cahan P; Zhao Y; Yourick JJ; Sprando RL
Stem Cell Res Ther; 2020 Sep; 11(1):393. PubMed ID: 32917265
[TBL] [Abstract][Full Text] [Related]
9. Patient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicity.
Choudhury Y; Toh YC; Xing J; Qu Y; Poh J; Li H; Tan HS; Kanesvaran R; Yu H; Tan MH
Sci Rep; 2017 Jan; 7():41238. PubMed ID: 28120901
[TBL] [Abstract][Full Text] [Related]
10. [Research advances in hepatocyte-like cells from human induced pluripotent stem cells and their application].
Cao YY; Zeng X
Zhonghua Gan Zang Bing Za Zhi; 2018 Jan; 26(1):69-72. PubMed ID: 29804367
[TBL] [Abstract][Full Text] [Related]
11. [Generation of Zone-specific Hepatocyte-like Cells from Human Induced Pluripotent Stem Cells for Accurate Prediction of Drug-induced Hepatotoxicity].
Mitani S
Yakugaku Zasshi; 2019; 139(12):1509-1512. PubMed ID: 31787637
[TBL] [Abstract][Full Text] [Related]
12. Stem-cell derived hepatocyte-like cells for the assessment of drug-induced liver injury.
Donato MT; Tolosa L
Differentiation; 2019; 106():15-22. PubMed ID: 30844688
[TBL] [Abstract][Full Text] [Related]
13. Concentration-dependent toxicogenomic changes of silver nanoparticles in hepatocyte-like cells derived from human induced pluripotent stem cells.
Gao X; Li R; Sprando RL; Yourick JJ
Cell Biol Toxicol; 2021 Apr; 37(2):245-259. PubMed ID: 32447489
[TBL] [Abstract][Full Text] [Related]
14. Prediction of drug-induced immune-mediated hepatotoxicity using hepatocyte-like cells derived from human embryonic stem cells.
Kim DE; Jang MJ; Kim YR; Lee JY; Cho EB; Kim E; Kim Y; Kim MY; Jeong WI; Kim S; Han YM; Lee SH
Toxicology; 2017 Jul; 387():1-9. PubMed ID: 28645575
[TBL] [Abstract][Full Text] [Related]
15. Liver biopsy derived induced pluripotent stem cells provide unlimited supply for the generation of hepatocyte-like cells.
Calabrese D; Roma G; Bergling S; Carbone W; Mele V; Nuciforo S; Fofana I; Campana B; Szkolnicka D; Hay DC; Tchorz J; Bouwmeester T; Wieland S; Heim MH
PLoS One; 2019; 14(8):e0221762. PubMed ID: 31465481
[TBL] [Abstract][Full Text] [Related]
16. Pluripotent stem cell-derived hepatocyte-like cells.
Schwartz RE; Fleming HE; Khetani SR; Bhatia SN
Biotechnol Adv; 2014; 32(2):504-13. PubMed ID: 24440487
[TBL] [Abstract][Full Text] [Related]
17. Functionally Enhanced Human Stem Cell Derived Hepatocytes in Galactosylated Cellulosic Sponges for Hepatotoxicity Testing.
Tasnim F; Toh YC; Qu Y; Li H; Phan D; Narmada BC; Ananthanarayanan A; Mittal N; Meng RQ; Yu H
Mol Pharm; 2016 Jun; 13(6):1947-57. PubMed ID: 27157693
[TBL] [Abstract][Full Text] [Related]
18. A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host.
Sa-Ngiamsuntorn K; Wongkajornsilp A; Phanthong P; Borwornpinyo S; Kitiyanant N; Chantratita W; Hongeng S
Virol J; 2016 Apr; 13():59. PubMed ID: 27044429
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of human foreskin fibroblast-derived induced pluripotent stem cells into hepatocyte-like cells.
Wang J; Zhao P; Wan Z; Jin X; Cheng Y; Yan T; Qing S; Ding N; Xin S
Cell Biochem Funct; 2016 Oct; 34(7):475-482. PubMed ID: 27569862
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive transcriptomic comparison of hepatocyte model systems improves selection of models for experimental use.
Ardisasmita AI; Schene IF; Joore IP; Kok G; Hendriks D; Artegiani B; Mokry M; Nieuwenhuis EES; Fuchs SA
Commun Biol; 2022 Oct; 5(1):1094. PubMed ID: 36241695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
